As of August 2026, according to Cintas's current financial statements, the company's 12-month EPS is $4.97. For the year 2026, the company recorded an earnings per share (EPS) of $4.97, which marks an increase compared to its EPS of $4.48 in 2025. Cintas's earnings per share for the quarterly report ending on May 31, 2026 reached $1.27.
The annual EPS for the year 2026 was $4.97, an increase of 10.9% from $4.48 in 2025. For the fiscal quarter that ended on May 31, 2026, the per-share earnings was $1.27, showing a 14.4% increase from the same quarter last year. For the twelve months ending May 2026, the EPS is $4.97. For the year 2025, the yearly earnings per share was $4.48, marking an increase of 16.4% from 2024.
During the last 12 months, Cintas has seen an EPS growth of 14.4% (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of 14.6% per year. During the last 5 years, the company had an average EPS growth rate of 13.6%. When measured over a ten-year period, CTAS's average EPS growth rate was 12.2%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| GNTX Gentex Corp | 13.12 | -1.7% | 8.6% | 4.3% |
| HCSG Healthcare Services Group Inc | 13.47 | 51.9% | 21.3% | -9.1% |
| ABM ABM Industries Inc | 18.36 | 102.3% | -8.8% | N/A |
| CTAS Cintas Corporation | 41.17 | 10.9% | 14.6% | 13.6% |
| ARMK Aramark | 41.89 | 24% | 17.7% | N/A |
| UNF Unifirst Corp | 44.26 | 2.7% | 13.4% | 2.2% |
All data is based on quarterly TTM periods, unless otherwise specified.